文献速递关节外科

倾向评分匹配比较Crowe I型发育性髋关节发育不良与原发性骨关节炎全髋关节置换术后的患者报告结局

Propensity Score-Matched Comparison of Patient-Reported Outcomes Between Crowe I Developmental Dysplasia of the Hip and Primary Osteoarthritis Following Total Hip Arthroplasty.
PubMed 文献 · J Arthroplasty · 2026-06-13

本研究通过倾向评分匹配比较Crowe I型发育性髋关节发育不良(DDH)与原发性骨关节炎(OA)患者全髋关节置换术(THA)后的患者报告结局(PROM)、翻修率和假体生存率。匹配后每组105髋,结果显示两组在所有时间点的PROM均无显著差异,翻修率和假体生存率也无显著差异。术前功能状态而非基础诊断是达到最小临床重要差异的主要预测因素。

要点

  • Crowe I型DDH与OA患者THA术后中期PROM相当。
  • 两组翻修率和假体生存率无显著差异。
  • 术前功能状态是达到MCID的主要预测因素。

核心结论

  • 在倾向评分匹配队列中,Crowe I型DDH与OA患者THA术后中期PROM、翻修率和假体生存率相当。
  • 术前功能状态而非基础诊断是达到最小临床重要差异的主要预测因素。

研究设计与样本

  • 单外科医生病例日志的回顾性综述,采用倾向评分匹配,得到105例DDH髋和105例OA髋。
  • 主要结局为术前、术后1年和至少两年最终随访时的mHHS、HOOS-JR、VAS疼痛和UCLA活动评分。
  • 次要结局包括Kaplan-Meier分析假体生存率、多变量逻辑回归分析MCID和SCB达成、翻修率以及影像学评估下肢长度差异和髋臼倾斜度。

主要发现

  • 任何时间点任何PROM均无显著组间差异,协方差分析证实四种PROM的调整后最终评分等效。
  • 两组中超过92%的患者在mHHS、HOOS-JR和VAS上达到最小临床重要差异。
  • DDH组有4例翻修,OA组有3例,翻修率无显著差异;Kaplan-Meier生存分析显示组间无显著差异。

关键数值与推荐

  • mHHS、HOOS-JR和VAS的MCID达成率在两组均超过92%。
  • 翻修率:DDH组4例,OA组3例,无显著差异。

临床怎么用

  • 当代THA对Crowe I型DDH和OA患者提供相似的临床获益。
  • 术前功能状态是达到MCID的主要预测因素,应关注术前功能优化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Total hip arthroplasty (THA) is commonly performed for Crowe I developmental dysplasia of the hip (DDH) and primary osteoarthritis (OA), but comparative survivorship and patient-reported outcome measure (PROM) data remain limited with mixed findings. This study aimed to compare PROMs, revision rates, and implant survivorship between propensity score-matched THA patients who had Crowe I DDH and OA. METHODS: A retrospective review of a single surgeon's case log was performed to identify patients with a diagnosis of DDH or OA and underwent THA. Propensity score matching was utilized, yielding 105 DDH hips and 105 OA hips. The primary outcomes were modified Harris Hip Score (mHHS), Hip disability and Osteoarthritis Outcome Score-Joint Replacement (HOOS-JR), visual analog scale (VAS) for pain, and University of California, Los Angeles Activity Score (UCLA) collected preoperatively, at 1 year, and at minimum two-year final follow-up. The secondary outcomes included implant survivorship via Kaplan-Meier analysis, multivariable logistic regressions for minimal clinically important difference and substantial clinical benefit achievement, revision rates, and radiographic assessment of leg-length discrepancy and acetabular inclination. RESULTS: There were no significant between-group differences in any PROM at any time point. Analysis of covariance confirmed equivalent adjusted final scores across all four PROMs. Minimal clinically important difference was achieved in over 92% of both cohorts for mHHS, HOOS-JR, and VAS. There were four revisions in the DDH group and three in the OA group; revision rates did not differ significantly. Kaplan-Meier survivorship analysis showed no significant difference between groups. CONCLUSIONS: In this propensity score-matched series, Crowe I DDH and OA patients achieved comparable midterm PROMs, revision rates, and implant survivorship after THA. Furthermore, preoperative functional status, rather than underlying diagnosis, was the primary predictor of achieving minimal clinically important difference. These findings suggest that contemporary THA provides similar clinical benefits across both diagnoses.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Saluja A, Eschert J, Ren R, et al. Propensity Score-Matched Comparison of Patient-Reported Outcomes Between Crowe I Developmental Dysplasia of the Hip and Primary Osteoarthritis Following Total Hip Arthroplasty. J Arthroplasty. 2026. PMID: 42285326. doi:10.1016/j.arth.2026.06.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。